Recently, some researchers found that high expression of CBX3 promoted ovarian cancer cell proliferation and was significantly related to unfavorable progression and chemoresistance, impacting the treatment outcomes of OV patients [47]. Here, CBX3 is linked to ovarian carcinoma.